Stryker Operating Expenses 2010-2024 | SYK

Stryker operating expenses for the twelve months ending December 31, 2024 were $18.906B, a 13.82% increase year-over-year.

  • Stryker annual operating expenses for 2024 were $18.906B, a 13.82% increase from 2023.
  • Stryker annual operating expenses for 2023 were $16.61B, a 6.42% increase from 2022.
  • Stryker annual operating expenses for 2022 were $15.608B, a 7.46% increase from 2021.

Stryker Operating Expenses 2010-2024 | SYK

  • Stryker annual operating expenses for 2024 were $18.906B, a 13.82% increase from 2023.
  • Stryker annual operating expenses for 2023 were $16.61B, a 6.42% increase from 2022.
  • Stryker annual operating expenses for 2022 were $15.608B, a 7.46% increase from 2021.
Related Stocks
Company NameMarket
Cap
Abbott Laboratories (ABT)$221.8B
Boston Scientific (BSX)$151.4B
EssilorLuxottica (ESLOY)$125.1B
Medtronic (MDT)$117.2B
Lonza Group Ag (LZAGY)$46B
Haleon (HLN)$43.1B
GE HealthCare Technologies (GEHC)$40.1B
ResMed (RMD)$37.1B
Terumo (TRUMY)$28.9B
Koninklijke Philips (PHG)$25.6B
Zimmer Biomet Holdings (ZBH)$22.1B
Insulet (PODD)$19.4B
Baxter (BAX)$16.7B
Smith & Nephew SNATS (SNN)$11.1B
BellRing Brands (BRBR)$10.1B
Sunny Optical Technology (SNPTF)$10B
Bio-Rad Laboratories (BIO)$10B
Demant (WILYY)$8.7B
Lantheus Holdings (LNTH)$6.4B
ICU Medical (ICUI)$4.1B
Prestige Consumer Healthcare (PBH)$3.9B
Envista Holdings (NVST)$3.7B
Haemonetics (HAE)$3.4B
Perrigo (PRGO)$3.4B
GN Store Nord (GNNDY)$3B
Shandong Weigao Medical Polymer (SHWGF)$3B
QuidelOrtho (QDEL)$2.9B
Neogen (NEOG)$2.5B
LeMaitre Vascular (LMAT)$2.2B
AtriCure (ATRC)$2.1B